NICOLE WILLIAMSON: Open Payments
NPI 1326826959 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Eisai Inc. | 1 | $113 |
| SK Life Science, Inc. | 1 | $93 |
| ABBVIE INC. | 2 | $46 |
| Lundbeck LLC | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| CSL Behring | 1 | $15 |
Products named: INGREZZA, Leqembi, XCOPRI, QULIPTA, ULTOMIRIS, VYEPTI, REXULTI, NURTEC ODT.
Industry payments across FL — which companies pay providers there.
